LANZHOU -- Heavy ion medical accelerators developed by Chinese researchers entered clinical testing for cancer patients in Northwest China's Gansu province this month, researchers said.Cancer radiation treatments employing heavy-ion accelerators can bombard a target with high-energy electrons to kill cancer cells.Xiao Guoqing, head of the Institute of Modern Physics under the Chinese Academy of Sciences, said it is widely considered the most effective way of fighting tumors.Compared to traditional therapy such as radiation, heavy ion treatment is considered to have more balanced properties with less radiation on healthy cells. The treatment period is shorter and the therapy could more effectively control cancer cells.The institute, based in Lanzhou, capital of northwest China's Gansu Province, developed the accelerators in 2015. It took two years for the accelerators to undergo medical equipment testing. Registration and testing were completed in April this year and clinical tests began.Currently, the institute has produced two sets of the cancer treatment equipment, one each in Lanzhou and Wuwei city, which has a high rate of stomach cancer.Patients were selected from Gansu Provincial Cancer Hospital and Wuwei Cancer Hospital. Testing is under way for cancer treatment for the head, neck, chest, abdomen, pelvis and limbs.In order to ensure the safety of the tests, 36 leading doctors in cancer treatment were assigned to oversee the tests.Xiao said the domestically developed equipment marks the end of China's dependence on imports. The institute started basic research into the technology in 1993.Currently very few hospitals in China offer heavy ion cancer treatment in China. Shanghai Proton and Heavy Ion Center uses imported equipment from Germany for cancer treatment. There is a long wait for the treatment at the Shanghai hospital.A report published by the National Cancer Center in 2017 showed that China has nearly 25 percent of the world's new cancer cases, with 10,000 cancer patients added per day. Every year, there are two million cancer-induced deaths. Lung, breast and stomach cancers are the most common types. debossed wristbandprintable wristbandsthe wristband factoryrubber bracelets custom cheapsilicone rubber bandscoloured wristbandsmake rubber bracelets
A Beijing woman became the first Chinese to received the HPV 9-valent vaccine in the Chinese mainland on Wednesday morning as the vaccine was made available in Boao, South China's Hainan province.The HPV 9-valent vaccine, only available at Boao Super Hospital at the Boao Lecheng International Medical Tourism Pilot Zone in Hainan for now, is specifically designed for women between the ages of 16 and 26. The price for the series of three injections is 5,800 yuan (908 dollars).The HPV vaccine helps protect against cancers and genital warts caused by the human papillomavirus.Individuals can receive the vaccines only by making an appointment on the telephone, as the supply is still limited. Only 6,000 vaccines in the first batch are available so far. That means it can only meet the needs of a maximum of 2,000 people.Boao is the first place to offer HPV 9-valent vaccines in the Chinese mainland, thanks to the preferential polices it enjoys.Boao Lecheng International Medical Tourism Pilot Zone, where Boao Super Hospital is located, is the only of its kind in China that enjoys nine preferential polices, such as special permission in importing medical technology, medical equipment and medicine.The pilot zone is allowed to import HPV 9-valent vaccines and other drugs without seeking permission via the central government's certain procedures in line with the nine preferential polices.Every year tens of thousands of Chinese women go overseas, as far as the Unite States, to receive the vaccines due to the inadequate supply in the domestic market, according to media reports.The pilot zone will work with top hospitals and experts in the healthcare sector to further exploit the advantages of preferential polices to provide better service for customers right at home, said He Pengfei, deputy director of the administrative committee of the Boao Lecheng pilot zone.
